Streetbeat News

Regulatory

KYMR

Kymera Therapeutics has presented preclinical data for KT-621, targeting TH2-driven allergic and atopic diseases. The company plans to start a Phase 1 trial in the second half of 2024, with results expected in the first half of 2025.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 11:03 am

INVH

Invitation Homes Inc, the largest U.S. landlord of single-family homes, faces FTC fines for alleged unfair and deceptive practices against renters. The company has agreed to a $48 million settlement to refund affected consumers and must change its business practices.

Portfolio Pulse from Vandana Singh

September 25, 2024 | 10:53 am

GIB

CGI has signed the European Union Artificial Intelligence (AI) Act Pledge, demonstrating its commitment to ethical AI practices as part of the European Commission's AI Pact.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 10:32 am

MRK

The Japanese Ministry of Health has approved new indications for Merck's Keytruda in treating certain lung and urothelial cancers. This includes its use in combination with chemotherapy for non-small cell lung carcinoma and with Padcev for urothelial carcinoma.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 10:31 am

BMY

TSVT

2seventy bio and Bristol Myers Squibb have decided to discontinue enrollment in the Phase 3 KarMMa-9 study due to improvements in the NDMM treatment landscape and a review of the business case.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 10:03 am

ALVO

Alvotech has initiated a confirmatory patient study for AVT16, a biosimilar candidate to Entyvio (vedolizumab). This development is a significant step in Alvotech's biosimilar pipeline.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 9:05 am

AAPL

AMZN

META

FTC Chair Lina Khan warns about the potential misuse of AI by airlines for price discrimination, particularly targeting vulnerable travelers. The FTC is investigating AI's role in price discrimination, raising concerns about tech companies' data practices.

Portfolio Pulse from Benzinga Neuro

September 25, 2024 | 8:57 am

BK

COIN

BNY Mellon has received an exemption from the SEC's SAB 121 rule, allowing it to enter the cryptocurrency custody market without reflecting these assets on its balance sheet. This move could challenge Coinbase's dominance in holding assets for Bitcoin and Ethereum ETFs.

Portfolio Pulse from Aniket Verma

September 25, 2024 | 8:34 am

LEU

Centrus Energy is advocating for Congress to allocate $3.4 billion in funding towards American-made nuclear fuel technology to reduce dependency on Russian nuclear fuel. Centrus aims to expand its American Centrifuge Plant in Ohio to produce Low-Enriched Uranium (LEU) and High-Assay, Low-Enriched Uranium (HALEU) for current and next-generation reactors. This initiative requires a public-private partnership and federal investment.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 6:47 am

NVVE

Nuvve Holding Corp. has executed a 1-for-10 reverse stock split to regain compliance with Nasdaq's Bid Price Rule. The company has 652,727 shares outstanding and advises shareholders to protect their shares against market manipulation.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 6:41 am